Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so… Read More »The Millennial sweet tooth (Sector Roundup: Week 10)
A Genetic Link I recently started watching Netflix’s Archive 81 with my girlfriend. Although we have only watched the first episode, there is a clear focus… Read More »Settling the score with schizophrenia (Sector Roundup: Week 6)
Tetra Bio-Pharma (TBP.T) received Health Canada’s approval for their amendment of a phase I study involving the safety profile of low and moderate doses of… Read More »Tetra Bio-Pharma (TBP.T) latest trial aims to answer the questions about CBD’s efficacy
Tetra Bio-Pharma (TBP.T) (“Tetra”) is a biopharmaceutical company focused on cannabinoid-derived drug discovery and development. The Company has an FDA and Health Canada cleared clinical… Read More »Tetra Bio-Pharma (TBP.T): A Closer Look
[image credit: https://weedit.network/] The overall health of the cannabis sector still isn’t good. Think crypto and blockchain in the winter of 2018 and you get… Read More »What’s Going On In Cannabis: A Mini Roundup
Tetra Bio-Pharma (TBP.T) announced today that the Central Ethics Committee has approved the proposed protocol modifications allowing additional immediate release oral opioids to be used… Read More »Tetra Bio-Pharma (TBP.T) Accelerates REBORN1© Trial
Tetra Bio-Pharma (TBP.T) announced today that Health Canada has accepted the Company’s New Drug Submission (NDS) for REDUVO™ and has formally entered the final review… Read More »Tetra Bio-Pharma’s (TBP.T) REDUVO™ Enters Final Review with Health Canada, Finish Line in Sight
